- Home
- PRME vs AAM Comparison
PRME vs AAM Comparison
Compare PRME & AAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRME
- AAM
- Stock Information
- Founded
- PRME 2019
- AAM 2024
- Country
- PRME United States
- AAM United States
- Employees
- PRME N/A
- AAM N/A
- Industry
- PRME Medicinal Chemicals and Botanical Products
- AAM
- Sector
- PRME Health Care
- AAM
- Exchange
- PRME Nasdaq
- AAM Nasdaq
- Market Cap
- PRME 424.9M
- AAM 441.9M
- IPO Year
- PRME 2022
- AAM 2024
- Fundamental
- Price
- PRME $3.20
- AAM $10.06
- Analyst Decision
- PRME Strong Buy
- AAM
- Analyst Count
- PRME 8
- AAM 0
- Target Price
- PRME $13.86
- AAM N/A
- AVG Volume (30 Days)
- PRME 1.1M
- AAM 93.9K
- Earning Date
- PRME 11-12-2024
- AAM 01-01-0001
- Dividend Yield
- PRME N/A
- AAM N/A
- EPS Growth
- PRME N/A
- AAM N/A
- EPS
- PRME N/A
- AAM N/A
- Revenue
- PRME $800,000.00
- AAM N/A
- Revenue This Year
- PRME N/A
- AAM N/A
- Revenue Next Year
- PRME $21.23
- AAM N/A
- P/E Ratio
- PRME N/A
- AAM N/A
- Revenue Growth
- PRME N/A
- AAM N/A
- 52 Week Low
- PRME $2.85
- AAM $9,600.00
- 52 Week High
- PRME $9.86
- AAM $15,000.00
- Technical
- Relative Strength Index (RSI)
- PRME 37.97
- AAM N/A
- Support Level
- PRME $2.85
- AAM N/A
- Resistance Level
- PRME $4.49
- AAM N/A
- Average True Range (ATR)
- PRME 0.33
- AAM 0.00
- MACD
- PRME -0.12
- AAM 0.00
- Stochastic Oscillator
- PRME 18.82
- AAM 0.00
About PRME Prime Medicine Inc.
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.
About AAM AA Mission Acquisition Corp. Class A Ordinary Shares
AA Mission Acquisition Corp is a blank check company.